Trump administration moves to cut obesity drug prices to $149 a month
TL;DR Summary
The Trump administration is close to finalizing deals with Eli Lilly and Novo Nordisk to offer obesity drugs at $149/month, potentially including Medicare coverage, aiming to make these popular but expensive medications more affordable for consumers.
- Trump administration nears deals with pharmaceutical companies to offer obesity drugs for $149 a month CNN
- White House nears deal to lower prices for weight loss drugs NBC News
- Eli Lilly, Novo Nordisk negotiating deal with Trump administration on obesity drug prices ABC News
- White House nears deal to lower obesity drug prices for Medicare coverage The Washington Post
- Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149 The Wall Street Journal
Reading Insights
Total Reads
1
Unique Readers
16
Time Saved
3 min
vs 4 min read
Condensed
95%
663 → 36 words
Want the full story? Read the original article
Read on CNN